Acquisition of HD Scientific

Acquisition of HD Scientific

June 01, 2013

Trajan Scientific and Medical (Trajan) subsidiary Grale Scientific has acquired the consumables business of HD Scientific to become Grale HDS.

HDS consumables include a range of quality microscope slides and coverslips manufactured in Germany, as well as the Clinipure range of pathology stains and products.

The addition of a Sydney office and warehouse enables Grale HDS to better serve customers all over Australia.




Also in News

Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti

November 30, 2020

Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.

This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.

Read More

Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions

November 11, 2020

In celebration of International Pathology Day, Trajan Scientific and Medical (Trajan) is proud to announce a new partnership with ScyTek Laboratories (ScyTek) to deliver quality immunohistochemistry (IHC) solutions.

Read More

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More